Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KEMZYME is a multi-enzyme feed additive developed by Kemin Industries, designed to enhance the digestive efficiency and nutritional utilization of feed in livestock, particularly poultry and swine. The product consists of a synergistic blend of exogenous enzymes, typically including xylanase, beta-glucanase, alpha-amylase, cellulase, and protease. These enzymes target non-starch polysaccharides (NSPs), starches, and proteins that are otherwise resistant to the animal's endogenous digestive processes. By catalyzing the hydrolysis of these complex substrates, KEMZYME reduces the viscosity of intestinal contents and improves the release of encapsulated nutrients from the feed matrix. This mechanism leads to improved feed conversion ratios (FCR), enhanced growth performance, and better overall gut health in production animals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on KEMZYME.